HomeInsightsPE

Lyka Labs Ltd PE Ratio

Lyka Labs Ltd PE Ratio

stocks purchased

₹ 0.4 Cr

Volume Transacted

(Dec 13, 2024)

stocks purchased

21.9 K

Stocks Traded

(Dec 13, 2024)

Last Updated on: Dec 14, 2024

Image

Lyka Labs Ltd

NSE: LYKALABS

PE

181.6

Last updated on: Dec 14, 2024

Key Highlights

  • The P/E Ratio of Lyka Labs Ltd is 181.6 as of 14 Dec 9.00 AM .
  • The P/E Ratio of Lyka Labs Ltd changed from 10 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Latest Trading Price of Lyka Labs Ltd is ₹ 161.65 as of 13 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Lyka Labs Ltd

No data available

Company Fundamentals for Lyka Labs Ltd

No data available

Image

Lyka Labs Ltd

NSE: LYKALABS

Share Price

₹ 161.65

-4.65 (-2.80%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Lyka Labs Ltd

1M

1Y

3Y

5Y

Monitoring Lyka Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Dec 2024161.65
12 Dec 2024166.3
11 Dec 2024168.8
10 Dec 2024173.2
09 Dec 2024170.75
06 Dec 2024162.25
05 Dec 2024166.5
04 Dec 2024165
03 Dec 2024163.6
02 Dec 2024166.35

SWOT Analysis Of Lyka Labs Ltd

Strength

1

S

Weakness

4

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Lyka Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Lyka Labs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Lyka Labs Ltd181576
Sun Pharmaceuticals Industries Ltd384,35,179
Divis Laboratories Ltd851,55,995
Cipla Ltd251,16,890
Torrent Pharmaceuticals Ltd651,13,295
Mankind Pharma Ltd501,05,787

Key Valuation Metric of Lyka Labs Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Lyka Labs Ltd

No data available

* All values are in crore

Historical Revenue of Lyka Labs Ltd

No data available

* All values are in crore

Historical EBITDA of Lyka Labs Ltd

No data available

* All values are in crore

Historical Net Profit of Lyka Labs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Lyka Labs Ltd

No data available

* All values are in %

About Lyka Labs Ltd

  • Initially manufacturing formulations, Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83.
  • It also added a range of ayurvedic and animal health care products over the years.
  • In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan.
  • Lyka Exports is the subsidiary of the company. The company offers a broad range of antibiotics used as life-savers and to treat minor infections.
  • It has a fairly widespread product base with tropical steroids for skin disorders, anti-cancer products, cardio-vascular drugs and anti-inflammatory products.

Lyka Labs Ltd News Hub

News

Lyka Labs reports consolidated net profit of Rs 1.44 crore in the June 2024 quarter

Net profit of Lyka Labs reported to Rs 1.44 crore in the quarter ended June 2024 as agains...

Read more

2024-08-09 00:00:00

News

Lyka Labs to hold board meeting

Lyka Labs will hold a meeting of the Board of Directors of the Company on 9 August 2024. P...

Read more

2024-08-02 00:00:00

News

Lyka Labs to hold board meeting

Lyka Labs will hold a meeting of the Board of Directors of the Company on 11 October 2024 ...

Read more

2024-10-04 00:00:00

News

Lyka Labs announces board meeting date

Lyka Labs will hold a meeting of the Board of Directors of the Company on 12 November 2024...

Read more

2024-10-23 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Lyka Labs Ltd

What is the current PE Ratio of Lyka Labs Ltd?

The Current PE Ratio of Lyka Labs Ltd is 181.63 as on 14 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 14 Dec 2024.

What was the PE Ratio of Lyka Labs Ltd last year?

The PE Ratio of Lyka Labs Ltd was 0.0 last year, now the PE ratio is 181.63, showing a year-on-year growth of -%.

What does the PE Ratio of Lyka Labs Ltd indicate about its stock?

The PE Ratio of Lyka Labs Ltd is 181.63. This ratio indicates that investors are willing to pay 181.63 times the earnings per share for each share of Lyka Labs Ltd.

What is the PE Ratio Growth of Lyka Labs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Lyka Labs Ltd grew by -% whereas, the EPS ratio grew by 45.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions